DWP
NVO

Destiny Wealth Partners’s Novo Nordisk NVO Stock Holding History

Destiny Wealth Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,192
Closed -$43.8K – 790
2026
Q1 		$43.8K Buy
+1,192
New +$56.5K ﹤0.01% 454
2023
Q1 		– Sell
-444
Closed -$30.1K – 476
2022
Q4 		$30.1K Buy
444
+92
+26% +$5.39K 0.01% 354
2022
Q3 		$18K Hold
352
– – ﹤0.01% 369
2022
Q2 		$20K Buy
352
+86
+32% +$4.77K ﹤0.01% 361
2022
Q1 		$15K Hold
266
– – ﹤0.01% 405
2021
Q4 		$15K Hold
266
– – ﹤0.01% 415
2021
Q3 		$13K Buy
+266
New +$12.9K ﹤0.01% 405
2021
Q2 		– Sell
-266
Closed -$9K – 393
2021
Q1 		$9K Hold
266
– – ﹤0.01% 418
2020
Q4 		$9K Buy
+266
New +$9.19K ﹤0.01% 419

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Destiny Wealth Partners's NVO Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 1,192 shares — an estimated $43.8K sold.

Destiny Wealth Partners first reported a position in NVO in Q4 2020 and held it in 9 quarters. The position peaked at $43.8K in Q1 2026. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Destiny Wealth Partners reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Destiny Wealth Partners sold 1,192 Novo Nordisk shares in Q2 2026, an estimated $43.8K.
  • Destiny Wealth Partners first reported a position in Novo Nordisk in Q4 2020 and held it in 9 quarters.
  • Destiny Wealth Partners's Novo Nordisk position peaked at $43.8K in Q1 2026.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.